Application Study of Nebulized Low-Dose Azithromycin in the Treatment of Community-Acquired Pneumonia

  • Rong Fan Jingzhou First People's Hospital
  • Wei Xiao Jingzhou First People's Hospital
  • Weihua Hu Jingzhou First People's Hospital
  • Zhu Wu Jingzhou First People's Hospital
DOI: https://doi.org/10.18686/aem.v11i4.331
Keywords: Nebulized Low-Dose Azithromycin, Community-Acquired Pneumonia, Treatment Response Rate, Inflammatory Cytokines

Abstract

Objective: To analyze the effect of nebulized low-dose azithromycin in the treatment of community-acquired pneumonia. Methods: The selected research subjects were 68 patients with community-acquired pneumonia admitted to our hospital from January 2020 to January 2021. The patients were divided into control group and experimental group by random number table method. The control group was treated with normal saline inhalation (34 cases), and the experimental group was treated with aerosol low-dose azithromycin (34 cases). The treatment effects of the two groups were compared. Results: There were significant differences in the effective rates of treatment between the two groups, and the experimental group was higher (P<0.05). There were significant differences in inflammatory cytokine indexes between the two groups, and the experimental group was lower (P<0.05). Conclusion: The treatment effect of low-dose azithromycin in the treatment of patients with community-acquired pneumonia is definite, and it can be applied and promoted in clinical practice.

References

[1] Zhang SW. Comparison of the Efficacy of Azithromycin Sequential Therapy and Levofloxacin Sequential Regimen on Community-acquired Pneumonia [J]. Chinese Community Physician, 2022, 38(14): 10-12.

[2] Zhang J. Analysis of Azithromycin combined with Ceftriaxone in the Treatment of Outpatient Community-acquired Pneumonia [J]. Medical Diet and Health, 2020,18 (17): 78-80.

[3] Wang MH. Observation on the Efficacy of Aerosolized Low-dose Azithromycin in the Treatment of Community-acquired Pneumonia [J]. Strait Pharmacy, 2021, 33(07): 154-156.

[4] Li JQ, Tong J. Observation on the Efficacy of Aerosolized Low-dose Azithromycin in the Treatment of Community-acquired Pneumonia [J]. Modern Medicine and Health, 2019, 35(02): 179-182.
Published
2023-03-02
Issue
Vol 11, No 4 (2022)
Section
Original Research Article

Copyright (c) 2023 Rong Fan, Wei Xiao, Weihua Hu, Zhu Wu

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear

Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.